So 4 patients out of 12 that started the phase 1 study have shown stable or slight improvement.
The question is, is a 33% good enough, and what about the other 6 that's not accounted for, it appears they have the disease progressing
So 4 patients out of 12 that started the phase 1 study have...
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $60.84K | 317.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 120380 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 22618 | 3 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |